此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

POC Analysis of IO Blood Samples Within Critically Ill Patients

2019年3月6日 更新者:Jouni Nurmi, MD、Helsinki University Central Hospital

Point-of-care Analyses of Intraosseous Blood Samples Within Critically Ill Patients

This study aims to investigate whether point-of-care (POC) analysis of intraosseous (IO) blood samples from critically ill emergency patients are accurate enough for emergency decision making, in comparison with arterial point-of-care samples.

研究概览

地位

完全的

条件

详细说明

Intravenous access is sometimes difficult to achieve due to vasoconstriction or centralization of circulation. Feasible IO-access with power-driven device is a standard alternative method of vascular access for critically ill patients. It is still unclear whether results of IO samples agree with venous or arterial blood samples so that they could be used in clinical decision-making.

After intraosseous access has been established for fluid resuscitation or medication, a common practice is to aspirate a small amount of blood to verify the proper location of the IO-needle.

POC-testing can provide emergency physicians or paramedics with important information about the patients. Could bone marrow samples be used for POC-testing instead of arterial or venous blood for emergency treatment decision-making or patient allocation?

Several animal and human studies have been published to investigate the correlation between IO versus venous or arterial blood values. Investigators of this study have performed a study in healthy volunteers and discovered that there is a good agreement for some laboratory parameters (pH, gluc, lact), but for K the agreement is poor. Our study group has as well performed a study in critically ill animals investigating the agreement during cardiac arrest and resuscitation. Te evidence about critically ill people is still week.

Aim of this study is to analyze the reliability of analysis of IO samples compared to arterial blood samples within critically ill adult emergency patients.

The hypotheses of this study are:

  1. Principally, it is possible to analyze IO blood samples with a POC device.
  2. The results are reliable enough to guide emergency treatment.

If both hypotheses prove to be true, the method can be immediately used in emergency medical situations, e.g. in searching for reversible causes of cardiac arrest.

Setting

Prospective, observational study with 35 prehospital emergency patients. The IO-samples are collected from the small amount of blood, which is aspirated from intraosseous space to confirm the correct needle placement. The IO needles are inserted to the patients for emergency treatment, not because of the study. Critically ill patients, to whom emergency doctors are inserting an intraosseous needle for emergency fluid or drug treatment, are included in the study.

Samples will be analyzed by using an i-STAT point of care analyzer (i-STAT® handheld, Abbot Point of Care Inc. U.S.A) using CG8+ cartridges to analyse Hb, Na, K, pH, pCO2, pO2, TCO2, HCO3, BE, and SpO2. The reliability of the results comparing the IO and arterial samples will be tested with Bland-Altman method by calculating the bias with 95% confidence intervals.

Ethical issues

The ethical committee of Medical Faculty of University of Helsinki has approved the research. Informed consent is waived.

Time plan

The samples will be collected during years 2017 - 2019. The analysis will be performed in the end of the year 2019.

研究类型

观察性的

注册 (实际的)

35

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Vantaa、芬兰
        • FinnHEMS10, Emergency Medicine and Services, Helsinki University Hospital

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

取样方法

非概率样本

研究人群

Emergency patients, which are met by the helicopter emergency unit during their normal tasks

描述

Inclusion Criteria:

  • need for point-of-care analysis
  • need for intraosseous access

Exclusion Criteria:

  • cardiac arrest
  • ability to understand the consent issues in Finnish, Swedish or English

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
干预/治疗
pre-hospital emergency patients
Patient in a need of an IO-access. Patient in a need of point-of-care laboratory analysis. Over 18 years. Alive (no Cardiac arrest.)
POC analysis with i-STAT POC analyser from the intraosseous and arterial blood

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
agreement between intraosseous (IO) and arterial POC analyses
大体时间:Samples are analysed immediately after the sample has been taken. Statistical analysis about the agreement performed when the whole data has been collected.
agreement analysed with Bland-Altman method from IO and arterial blood samples, which have been analysed with iSTAT point-of care analyser for following parameters: Hb, pH, BE, HCO3, pO2, pCO2, glucose, Na, K, iCa
Samples are analysed immediately after the sample has been taken. Statistical analysis about the agreement performed when the whole data has been collected.

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

合作者

调查人员

  • 首席研究员:Jouni Nurmi, M.D. Ph D、University of Helsinki, Helsinki University hospital

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2017年5月3日

初级完成 (实际的)

2019年1月29日

研究完成 (实际的)

2019年1月29日

研究注册日期

首次提交

2018年9月27日

首先提交符合 QC 标准的

2018年11月15日

首次发布 (实际的)

2018年11月19日

研究记录更新

最后更新发布 (实际的)

2019年3月8日

上次提交的符合 QC 标准的更新

2019年3月6日

最后验证

2019年3月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • 1234567890

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

point-of-care laboratory analysis的临床试验

3
订阅